Results 151 to 160 of about 8,955 (198)

Efficacy of vitamin B12 treatment on the adrenal gland of propylthiouracil-induced hypothyroid rats. [PDF]

Open Vet J
Ajeel MT, Saleh HS, Din AM, Alashkham F, Said RM.   +4 more
europepmc   +1 more source

Combinations of compound cold medicines should be used with caution: a case series. [PDF]

Front Med (Lausanne)
Guo J, Zhang T, Song S, Li J.
europepmc   +1 more source

Correlation between depressive-like behavior and gut microbiota in mice with hypothyroidism. [PDF]

World J Psychiatry
Guo HJ, Ma XQ, Li YT, Zhou ZH, Tao W, Jiang YH, Li XL, Zhang XL.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Pharmacokinetics of Propylthiouracil

Acta Pharmacologica Et Toxicologica, 1974
The half‐life of propylthiouracil was determined in 7 normal subjects after intravenous injection of 400 mg of the drug. An average value of 77 ± 17 minutes (mean ± S. D.) was found. As the concentration of the drug in the blood declined by a rapid phase followed by a more slow phase a two‐compartment model was used for further calculations, and the ...
L Skovsted
exaly   +3 more sources

Fulminant hepatic failure associated with propylthiouracil: A case report with treatment emphasis on the use of plasmapheresis

Journal of Clinical Apheresis, 2005
Propylthiouracil is a commonly used medication for hyperthyroidism. Though propylthiouracil-induced hepatotoxicity is a rarely encountered problem, death due to fulminant hepatic failure may occur.
Yücel Ustundag, Taner Bayraktaroglu, Ishak Ozel Tekin   +2 more
exaly   +2 more sources

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination

Vaccines, 2021
We report the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) after receiving the coronavirus disease 2019 (COVID-19) vaccine BNT162b (Pfizer–BioNTech).
Yasuaki Hirooka, Masafumi Sugiyama, Hirooka Yasuaki   +2 more
exaly   +2 more sources

The propylthiouracil dilemma

Current Opinion in Endocrinology, Diabetes & Obesity, 2012
To bring to the attention of healthcare professionals the additional information on propylthiouracil (PTU)-related hepatotoxicity, based on a reanalysis of medical files reported to the Food and Drug Administration (1982-2008) for acute liver failure in PTU-treated hyperthyroid patients, and propose recommendations for the clinical use of PTU. Thirteen
Glinoer, Daniel, Cooper, David
openaire   +3 more sources

Propylthiouracil

Reactions Weekly, 2015
  +7 more sources